Literature DB >> 28703923

Autophagy in neurodegenerative diseases: pathogenesis and therapy.

Fang Guo1, Xinyao Liu2, Huaibin Cai3, Weidong Le1,2,4.   

Abstract

The most prevalent pathological features of many neurodegenerative diseases are the aggregation of misfolded proteins and the loss of certain neuronal populations. Autophagy, as major intracellular machinery for degrading aggregated proteins and damaged organelles, has been reported to be involved in the occurrence of pathological changes in many neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. In this review, we summarize most recent research progress in this topic and provide a new perspective regarding autophagy regulation on the pathogenesis of neurodegenerative diseases. Finally, we discuss the signaling molecules in autophagy-related pathways as therapeutic targets for the treatment of these diseases.
© 2017 International Society of Neuropathology.

Entities:  

Keywords:  autophagy; neurodegenerative diseases; protein aggregation

Mesh:

Year:  2017        PMID: 28703923      PMCID: PMC5739982          DOI: 10.1111/bpa.12545

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  141 in total

1.  Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy.

Authors:  Sooyeon Lee; Yutaka Sato; Ralph A Nixon
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

Review 2.  Defects in trafficking bridge Parkinson's disease pathology and genetics.

Authors:  Asa Abeliovich; Aaron D Gitler
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

3.  Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis.

Authors:  Shoichi Sasaki
Journal:  J Neuropathol Exp Neurol       Date:  2011-05       Impact factor: 3.685

4.  Activation of Autophagic Flux against Xenoestrogen Bisphenol-A-induced Hippocampal Neurodegeneration via AMP kinase (AMPK)/Mammalian Target of Rapamycin (mTOR) Pathways.

Authors:  Swati Agarwal; Shashi Kant Tiwari; Brashket Seth; Anuradha Yadav; Anshuman Singh; Anubha Mudawal; Lalit Kumar Singh Chauhan; Shailendra Kumar Gupta; Vinay Choubey; Anurag Tripathi; Amit Kumar; Ratan Singh Ray; Shubha Shukla; Devendra Parmar; Rajnish Kumar Chaturvedi
Journal:  J Biol Chem       Date:  2015-07-02       Impact factor: 5.157

5.  Depletion of Beclin-1 due to proteolytic cleavage by caspases in the Alzheimer's disease brain.

Authors:  Troy T Rohn; Ellen Wirawan; Raquel J Brown; Jordan R Harris; Eliezer Masliah; Peter Vandenabeele
Journal:  Neurobiol Dis       Date:  2010-11-21       Impact factor: 5.996

6.  Genetic and functional analysis of TBK1 variants in Korean patients with sporadic amyotrophic lateral sclerosis.

Authors:  Young-Eun Kim; Ki-Wook Oh; Min-Young Noh; Minyeop Nahm; Jinseok Park; Su Min Lim; Ja-Hyun Jang; Eun-Hae Cho; Chang-Seok Ki; Seungbok Lee; Seung Hyun Kim
Journal:  Neurobiol Aging       Date:  2016-11-19       Impact factor: 4.673

Review 7.  Protein aggregation diseases: pathogenicity and therapeutic perspectives.

Authors:  Adriano Aguzzi; Tracy O'Connor
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

8.  The Beclin 1 interactome.

Authors:  Congcong He; Beth Levine
Journal:  Curr Opin Cell Biol       Date:  2010-01-22       Impact factor: 8.382

9.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.

Authors:  Han-Xiang Deng; Wenjie Chen; Seong-Tshool Hong; Kym M Boycott; George H Gorrie; Nailah Siddique; Yi Yang; Faisal Fecto; Yong Shi; Hong Zhai; Hujun Jiang; Makito Hirano; Evadnie Rampersaud; Gerard H Jansen; Sandra Donkervoort; Eileen H Bigio; Benjamin R Brooks; Kaouther Ajroud; Robert L Sufit; Jonathan L Haines; Enrico Mugnaini; Margaret A Pericak-Vance; Teepu Siddique
Journal:  Nature       Date:  2011-08-21       Impact factor: 49.962

10.  Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.

Authors:  Suzanne Lesage; Valérie Drouet; Elisa Majounie; Vincent Deramecourt; Maxime Jacoupy; Aude Nicolas; Florence Cormier-Dequaire; Sidi Mohamed Hassoun; Claire Pujol; Sorana Ciura; Zoi Erpapazoglou; Tatiana Usenko; Claude-Alain Maurage; Mourad Sahbatou; Stefan Liebau; Jinhui Ding; Basar Bilgic; Murat Emre; Nihan Erginel-Unaltuna; Gamze Guven; François Tison; Christine Tranchant; Marie Vidailhet; Jean-Christophe Corvol; Paul Krack; Anne-Louise Leutenegger; Michael A Nalls; Dena G Hernandez; Peter Heutink; J Raphael Gibbs; John Hardy; Nicholas W Wood; Thomas Gasser; Alexandra Durr; Jean-François Deleuze; Meriem Tazir; Alain Destée; Ebba Lohmann; Edor Kabashi; Andrew Singleton; Olga Corti; Alexis Brice
Journal:  Am J Hum Genet       Date:  2016-03-03       Impact factor: 11.025

View more
  62 in total

1.  Inhibition of mTOR Alleviates Early Brain Injury After Subarachnoid Hemorrhage Via Relieving Excessive Mitochondrial Fission.

Authors:  Yuchen Li; Pei Wu; Jiaxing Dai; Tongyu Zhang; Ji Bihl; Chunlei Wang; Yao Liu; Huaizhang Shi
Journal:  Cell Mol Neurobiol       Date:  2019-11-15       Impact factor: 5.046

2.  Possible Therapeutic Intervention Strategies for COVID-19 by Manipulating the Cellular Proteostasis Network.

Authors:  Mudassar Ali; Jyotirmoy Rajurkar; Priyanka Majumder; Mainak Pratim Jha; Rajasri Sarkar; Koyeli Mapa
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  ERK inhibition in glioblastoma is associated with autophagy activation and tumorigenesis suppression.

Authors:  Kang Yang; Lan Luan; Xinyu Li; Xu Sun; Jian Yin
Journal:  J Neurooncol       Date:  2021-11-19       Impact factor: 4.130

Review 4.  MicroRNA-96: A therapeutic and diagnostic tumor marker.

Authors:  Hamid Reza Rahimi; Majid Mojarrad; Meysam Moghbeli
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

Review 5.  Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.

Authors:  Erin T Williams; Xi Chen; P Anthony Otero; Darren J Moore
Journal:  Neurobiol Dis       Date:  2022-05-16       Impact factor: 7.046

6.  Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.

Authors:  Qihui Lian; Yuan Gao; Qian Li; Xian He; Xiaogang Jiang; Zhongjian Pu; Guoqiang Xu
Journal:  Protein J       Date:  2020-10-03       Impact factor: 2.371

7.  Galantamine Inhibits Aβ1-42-Induced Neurotoxicity by Enhancing α7nAChR Expression as a Cargo Carrier for LC3 Binding and Aβ1-42 Engulfment During Autophagic Degradation.

Authors:  Ming-Wei Lin; Yi-Hung Chen; Han-Ben Yang; Chi Chien Lin; Shih-Ya Hung
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

8.  Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury.

Authors:  Zi-Qi Shao; Shan-Shan Dou; Jun-Ge Zhu; Hui-Qing Wang; Chun-Mei Wang; Bao-Hua Cheng; Bo Bai
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

9.  E183K Mutation in Chalcone Synthase C2 Causes Protein Aggregation and Maize Colorless.

Authors:  Haixiao Dong; He Li; Yingjie Xue; Shengzhong Su; Shipeng Li; Xiaohui Shan; Hongkui Liu; Nan Jiang; Xuyang Wu; Zhiwu Zhang; Yaping Yuan
Journal:  Front Plant Sci       Date:  2021-06-23       Impact factor: 5.753

Review 10.  Recent Progress in Non-motor Features of Parkinson's Disease with a Focus on Circadian Rhythm Dysregulation.

Authors:  Yufei Liu; Long Niu; Xinyao Liu; Cheng Cheng; Weidong Le
Journal:  Neurosci Bull       Date:  2021-06-15       Impact factor: 5.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.